Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

Clinical trial NCT02768805 · COMPLETED

Trial details

NCT number: NCT02768805
Sponsor: Medicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Virus Diseases RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections

Start date: 2016-03-02
Primary completion: 2016-05-17
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.